One sentence summary: A biologically conjugated polysaccharide vaccine delivered by attenuated Salmonella Typhimurium provides protection against challenge of avian pathogenic Escherichia coli O1 infection. Editor: Ake Forsberg
INTRODUCTION
Avian pathogenic Escherichia coli (APEC) causes airsacculitis and colibacillosis, leading to economic losses in the poultry industry (Guabiraba and Schouler 2015) . Antibiotic treatment is a traditional efficient way to prevent APEC infection in poultry production; however, the emergence of multiple drug-resistant strains makes APEC not only a major antimicrobial resistancespreading source spread to other bacteria but also a source that can cause human infection via the food chain (Johnson et al. 2005; Mellata 2013) , posing a serious threat to public health. Thus, the development of an efficient vaccine is an alternative useful strategy to control the potential zoonotic risk to humans (Sadeyen et al. 2015) . Many attempts have been made to develop an effective vaccine against colibacillosis in poultry. Inactivated, recombinant subunit and live-attenuated vaccines focusing on common surface virulence factors have been previously investigated at the preclinical stage, and limited protection and no cross-protection is still a problem to be resolved (Salehi et al. 2012; Ghunaim, Abu Madi and Kariyawasam 2014) .
Serotypes of APEC O1, O2 and O78 are frequently implicated in field infections and have accounted for more than 85% of the APEC issues in China (Dho-Moulin and Fairbrother 1999; Wang et al. 2014) . Therefore, a vaccine capable of conferring protection against these three serotypes has the potential to control the majority of APEC outbreaks. O-antigen polysaccharide, located on the bacterial surface, is responsible for serotype classification in Gram-negative bacteria and is considered a good protective antigen due to its high immunogenicity (Nagy et al. 2006; DebRoy et al. 2016) . Vaccines based on polysaccharides have been investigated for years, and various polysaccharide-conjugated vaccines against pathogenic bacteria, including Haemophilus influenzae, Neisseria meningitidis and Streptococcus, are commercially available (Verez-Bencomo et al. 2004 ; American Academy of Pediatrics Committee on Infectious Diseases 2005; Schuerman et al. 2007 ). However, polysaccharide vaccines manufactured in this way are limited during the process of polysaccharide purification and ligation to carrier proteins, leading to high production costs and inconvenient administration routes due to the need of needles for vaccinations (Hecht et al. 2009; Tarahomjoo 2014) .
Oral live-attenuated Salmonella is often used as a platform to deliver heterologous antigens to induce humoral, mucosal and cell-mediated immune responses against heterologous antigens (Curtiss et al. 1994; Medina and Guzmán 2001; Cheminay and Hensel 2008) . Various candidate antigens including proteins and polysaccharides from several bacteria have been synthesized in live attenuated Salmonella, and most of the recombinant vaccines induced good protective immune responses (Attridge et al. 1990; Roland, Curtiss and Sizemore 1999; Cisar et al. 2007; Dharmasena et al. 2013) . Additionally, attenuated Salmonella vaccines are easily administered orally to induce immune responses and thus are applicable for mass immunizations of chicken farms.
APEC O1 is often isolated from clinical samples, accounting for about 5% and 10% poultry infection of APEC in China and in Germany, respectively (Ewers et al. 2007; Wang et al. 2014) . In this work, we developed a new method to assemble and express O1 O-antigen polysaccharide genes in attenuated Salmonella Typhimurium to prevent APEC infection. The phenotypes, characteristics and immune protection against APEC O1 of these strains were also evaluated.
MATERIALS AND METHODS

Bacterial strains, plasmids and growth conditions
The strains and plasmids used in this study are listed in Table 1 . MaV203 yeast cells (Life Technology, CA, USA) were grown in Yeast Peptone Dextrose (YPD) broth or on agar plates at 30
• C.
Salmonella Typhimurium and APEC strains were grown in LuriaBertani (LB) or on agar plates at 37
• C. Diaminopimelic acid (DAP) 
Plasmid construction
The primers used in this study are listed in Table 2 . To facilitate large DNA fragment cloning and assembly, the shuttle plasmid based on pYA3337 (Baek et al. 2009 ) and pYES1L was created. Briefly, the T1T2-pSC101-asd fragment and the TRP1-ARS4/CEN5-Spec fragment were amplified from pYA3337 using the primer pair pYA3337-F/R and from pYES1L using the primer pair pYES1L-F/R, respectively ( Table 2 ). The PCR products were digested with SbfI and NotI restriction enzymes. After the agarose-purified PCR products were ligated with T4 ligase, they were transformed into Top10-competent cells by electroporation, and a positive colony on the LB plate with spectinomycin was identified by PCR and sequencing. The resultant vector was named pSS26.
Assembling the gene cluster for O1 O-antigen polysaccharide synthesis in the plasmid
An APEC O1 O-antigen gene cluster with an inherent promoter (10,881 bp) was assembled into pSS26. Briefly, two segments of O1-1 (5551 bp) and O1-2 (5391 bp) were amplified from the APEC O1 genome using the primer pairs O1-1F/1R and O1-2F/2R, respectively, which share an end-terminal homologous sequence with each other (Gibson et al. 2008) . In addition, the linear vector fragment was amplified from the shuttle vector pSS26 with vector-F/R primer pairs, which share end-terminal homology with the adjacent fragments of O1-1 and O1-2 (Table 2 ). The linear cloning vector and the two fragments of O1 O-antigen cluster were co-transformed into MaV203 competent yeast cells via PEG/LiAc after gel purification (Gibson 2009 
O-antigen were named pSS27. All the plasmids constructed in this study were confirmed by DNA sequencing (BGI, Shenzhen, China).
Construction of attenuated Salmonella Typhimurium mutant
Attenuated S. Typhimurium strains were constructed for delivering APEC O1 O-antigen polysaccharide. The asd, crp, cya and rfbP deletions of S100 (Liu et al. 2016a) were performed by allelic exchange using suicide plasmid. The resulting strain of asd-66 was named S184, the mutant of asd-66 crp-24 cya-25 was named S739 (Liu et al. 2016b ) and rfbP45 was introduced by plasmid pYA4899 to S739 to generate the mutant asd-66 crp-24 cya-25 rfbP45, named S740 (Liu et al. 2016b) .
Lipopolysaccharide profile
The plasmid pSS27 was then electrotransformed into the mutant strains S739 and S740 and plated on LB agar to screen positive recombinant with the Asd-balanced lethal host-vector system (Nakayama, Kelly and Curtiss 1988) followed by PCR identification and slide agglutination. Silver staining and western blotting were further performed to detect the synthesis of O1 O-antigen polysaccharide in S. Typhimurium. Lipopolysaccharide (LPS) samples used for silver staining and western blotting detection were prepared and separated following the method described previously (Kong et al. 2011) . Silver staining was performed to detect the LPS profile. Western blotting with rabbit antiserum against serotype O1 APEC (Tianjin Biochip Corporation, Tianjin, China; 1:500) or rabbit antiserum against serotype O4 Salmonella (Ningbo Tianrun Bio-Pharmaceutical Co, Ningbo, China; 1:500) was probed to specifically detect O-antigen synthesis in Salmonella. The secondary antibody was HRP-conjugated goat anti-rabbit polyclonal antibody (Proteintech, Chicago, USA; 1:5000). Immunoblots were visualized by developing with Clarity ECL Western Blotting Substrate (Bio-Rad, CA, USA).
Plasmid stability evaluation
Two different ways were adopted to identify the stability of the APEC O1 O-antigen gene cluster expression carried by plasmid pSS27.
First, different generations of recombinant clones in S. Typhimurium were also tested by silver staining and western blotting as described above (Dharmasena et al. 2013) . The overnight cultures were continuously 1:1000 subcultured into fresh LB medium containing DAP (non-selective conditions) every 12 h for 3 days; the LPS profiles and reaction with rabbit antiserum against serotype O1 E. coli of 24, 48 and 72 h cultures were detected.
Another detection was performed according to the standard plasmid stability test protocol described before (Zhang et al. 2011) . Single colonies of the various strains were inoculated to 3 ml LB broth and grown overnight. The overnight cultures were continuously 1:1000 subcultured into fresh LB medium containing DAP (non-selective conditions) every 12 h for 3 days; the recombinant cell culture of each generation was serially diluted and spread onto LB agar plates containing DAP. Then, 100 single colonies were picked and patched on LB agar plates without any supplements (selective media) and on LB agar plates containing DAP. Plasmid stability was determined as the percentage of colonies growing on selective media after each of the five passages.
Phenotypic determination of attenuated Salmonella carrying plasmids
To determine the effect of plasmids pSS26 (empty vector) and pSS27 (APEC O1 polysaccharide) on the phenotypes of attenuated S. Typhimurium S739 and S740, we compared the growth curves, motility ability, and polymyxin B and DOC sensitivity of S739 and S740 carrying each plasmid in LB media according to described methods (Kong et al. 2011) . For the growth rate, overnight cultures were diluted to 0.05 of OD 600 in fresh LB broth and grown at 37
• C. The OD 600 of each strain was measured per hour until a stationary phase was reached. For the swimming and swarming motility, bacteria were grown to 0.8-0.9 of OD 600 in LB broth, harvested and washed twice in PBS. Three microliters of the washed cells was added to the center of LB plates with 0.3% and 0.6% agar, to measure growth diameter after incubation at 37
• C for 6 h. The polymyxin B and DOC sensitivity detection was performed as described previously (Xiao et al. 2015) . The ratio of the survival colony before and after treating was calculated to determine the resistance to both substances. All assays were repeated three times.
Immunization of attenuated Salmonella delivering APEC O1 O-antigen polysaccharide and determination of the protection efficacy in birds
The animal study was scheduled as described previously with some modification (Ghunaim, Abu Madi and Kariyawasam 2014) and performed in accordance with the Declaration of Helsinki and was carried out in accordance with the Animal Welfare Act and regulations related to animal experiments. In addition, the principles stated in the Guide for the Care and Use of Laboratory Animals was followed. The animal care protocols were approved by Sichuan Agricultural University (Ya'an, China; Approval No. 2011-028) . Salmonella strains were grown statically overnight in LB media at 37
• C. The overnight cultures were inoculated in 50 ml LB media at 1:100 on the following day and grown with aeration at 37
• C to 0.8-0.9 of OD 600 . The cells were suspended in 5 ml of buffered saline with gelatin (BSG). The concentration of bacteria was ∼10 10 CFU/ml, and the appropriate concentrations of Salmonella were adjusted for bird immunization. One-day-old Lohmann hens purchased from Chengdu Muxing poultry limited liability companies (Chengdu, China) were used to assess the immune responses and protection efficacy afforded by S. Typhimurium mutant synthesizing APEC O1 Oantigen polysaccharide. After acclimated for 10 days, birds were randomly divided into 10 treatment groups.
Immunization
The four groups and 30 10-day-old chickens in each group were used for oral immunization. Chickens were orally immunized with 100 μl BSG harboring 10 9 CFU of each of the four vaccine strains including S739 (pSS26, empty vector), S739 (pSS27, expressing APEC O1 O-antigen), S740 (pSS26, empty vector), S740 (pSS27, expressing APEC O1 O-antigen). The control group has 26 chickens that were inoculated with 100 μl BSG as a negative control. Birds were boosted using the same strains with the same dose on 14 days after the initial immunization. The same animal experiments were also performed to evaluate intramuscular (i.m.) immunization. The birds were intramuscularly immunized with 5.0 × 10 7 CFU of the same strains and same schedule used in oral immunization. The control group was intramuscularly injected with 100 μl BSG as a negative control. Birds were boosted using the same strains with the same dose on 14 days after the initial immunization.
Sample collection and challenge
Blood and intestinal mucus were collected from six birds from each group 10 days after the second immunization and stored at -70
• C for antibody detection by enzyme-linked immunosorbent assay (ELISA). After sample collection, half of the remaining birds (total 24 chickens/vaccine group, 20 chickens/BSG group) were challenged with 2.5 × 10 9 CFUs of APEC O1 serotype C24-2 strain by either the air sac route (12 chickens/vaccine group, 10 chickens/BSG group) or the i.m. route (12 chickens/vaccine group, 10 chickens/BSG group). APEC O1 serotype strain C24-2 was isolated from the infected chickens, and its LD 50 by the i.m. route is 5.62 × 10 6 , and by the air sac route is 3.98 × 10 6 .
Challenged chickens were monitored for 2 weeks, and deaths were recorded daily.
Anti-LPS antibody detection by ELISA
ELISA was performed to determine the levels of serum IgG and intestinal mucus IgA antibodies against LPS from both S. Typhimurium and APEC O1 after booster immunization. LPS extracted from S. Typhimurium S100 and APEC O1 C24-2 by hot phenol (Han et al. 2014) 
Statistical analyses
Statistical analyses were performed with GraphPad Prism version 5 software (Graph Software, San Diego, CA, USA). All results were presented as the means ± SEM of at least three independent experiments. The means were evaluated by one-way ANOVA followed by unpaired, two-tailed Student's t-tests. The differences in the survival rates among groups were analyzed by the log-rank sum test. A P value of < 0.05 was considered as a statistical significance.
RESULTS
Plasmid construction
The strategy used for constructing plasmid pSS26 was outlined in Fig. 1 ; the replication elements of ARS4/CEN5 and pSC101 ensure the shuttling of plasmid from Saccharomyces cerevisiae to Escherichia coli or Salmonella. The trp1 and asd genes guarantee positive colony selection from S. cerevisiae trp-negative and from bacteria with asd mutation, respectively. In addition, the major advantage of this plasmid is the Asd + balanced lethal host-vector system, ensuring the stability of the plasmid in bacterial hosts containing asd mutation without antibiotic pressure. The gene cluster for O1 O-antigen polysaccharide synthesis was successfully assembled into the shuttle vector pSS26 by yeast recombination, the positive colonies were obtained at the percentage of 45% and the yielded plasmid was named pSS27.
Analysis the synthesis of APEC O1 O-antigen polysaccharide in attenuated Salmonella
After the plasmid pSS27 was transformed into S739 and S740, positive colonies were detected by PCR and serum agglutination. Silver staining and western blotting analysis of LPS further indicated that pSS27 was functionally able to synthesize E. coli O1 O-antigen polysaccharide in Salmonella vaccines. Silver staining of LPS revealed that S740 (pSS26) strain generated only lipid Acore without O-antigen repeats ( Fig. 2A, lane 1) , while smooth LPS phenotype was restored in the S740 strain with pSS27 carrying the APEC O1 O-antigen gene cluster (lane 2). Unlike S740, LPS profiles of S739 (pSS26) (lane 3) and S739 (pSS27) (lane 4) were not distinguishable by silver staining. Further immunoblotting reaction with rabbit antiserum against E. coli O1 (Fig. 2B) demonstrated that all strains harboring pSS27 showed a similar reaction ladder to E. coli O1 C24-2, whereas strains harboring pSS26 or wild-type S. Typhimurium did not. Immunoblot reaction with rabbit antiserum against O4 serotype Salmonella (Fig.  2C ) also revealed that LPS ladders could be observed in the wildtype Salmonella and S739 ( asd-66 crp-24 cya-25) strains but not in the S740 ( asd-66 crp-24 cya-25 rfbP45), which has an rfbP mutation leading to loss of Salmonella own O-antigen polysaccharide. We observed that the LPS patterns from S739 and S740 carrying pSS27 were quite different from that of the wild-type E. coli C24-2. The difference of LPS patterns in two bacteria is due to the fact that E. coli and Salmonella have different regulator determinants Wzz protein to regulate O-antigen length during O-antigen synthesis in these two hosts (Kalynych, Morona and Cygler 2014) . Serum slide agglutination with antiserum against E. coli O1 also demonstrated that APEC O1 O-antigen polysaccharide was successfully synthesized and attached to the lipid A core of Salmonella vaccine strains S739 and S740 and was located on the surface of Salmonella (data not shown).
Determination of plasmid stability in attenuated Salmonella Typhimurium
The LPS profile of attenuated S. Typhimurium vaccine strain carrying pSS27 grown in LB broth supplemented with DAP from 24 h to 72 h cultures was detected by silver staining and western blotting. As shown in Fig. 3 , all strains from 24 h to 72 h cultures could express O-antigen polysaccharide (Fig. 3A) , and attenuated Salmonella vaccine strains harboring pSS27 were able to react with antiserum against E. coli O1 (Fig. 3B) , demonstrating that plasmid pSS27 carrying the heterologous APEC O1 O-antigen gene cluster was stably maintained in Salmonella strains and was able to synthesize APEC O1 O-antigen polysaccharide and attach to the surface of Salmonella.
The existence of plasmid pSS27 in S739 ( asd-66 crp-24 cya-25) and S740 ( asd-66 crp-24 cya-25 rfbP45) was also determined by plating actively growing cultures on both selective and non-selective medium. After five passages in 3-day culture, about 85% of vaccines S740 and S739 still contained the plasmids, indicating that the plasmid can stably maintain in the vaccine strain when grown without pressure (Fig. 3C) .
Evaluation of phenotypes of attenuated Salmonella Typhimurium delivering APEC O1 O-antigen
The growth rates of the vaccine strains S739 and S740 carrying either pSS26 or pSS27 were similar to wild-type S100. In addition, the swimming and swarming motility of strains carrying pSS27 (APEC O1) did not differ from those of strains carrying pSS26. Additionally, APEC O1 O-antigen gene cluster expression in S. Typhimurium had no effect on polymyxin B and DOC sensitivity, suggesting that the presence of heterologous O-antigen did not alter resistance to surface acting agents (Fig. 4) .
Detection of immune responses to LPS from both Salmonella Typhimurium and APEC O1
Both oral and i.m. immunization of S739 carrying either pSS26 or pSS27 elicited significantly higher IgG immune responses against LPS from S. Typhimurium than S740 and BSG control (P < 0.05), and i.m. immunization of S739 (pSS27) elicited higher IgG levels against LPS from S. Typhimurium than oral immunization (Fig. 5A) . Oral and i.m. immunization of both strains S739 and S740 carrying pSS27 induced significantly higher anti-APEC O1 LPS IgG levels in serum than immunization of strains carrying pSS26 (empty vector) (P < 0.05). S740 (pSS27) elicited higher IgG level against LPS from APEC O1 than did by S739 (pSS27), especially for i.m. administration (P < 0.01) (Fig. 5B) . 4) . However, the LPSs from strains with the empty plasmid pSS26 (lanes 1 and 3) and from S. Typhimurium S100 were not reactive to anti-E. coli O1 serum. (C) Immunoblot against anti-Salmonella O4 serum. Only S739 ( asd-66 crp-24 cya-25) (lanes 3 and 4) and Salmonella S100 (lane 5) could produce LPSs that reacted with Salmonella O4 serum. Western blotting detection against anti-E. coli O1 serum. All strains containing pSS27 reacted with antiserum against E. coli O1 and C24-2 strain. The stability of pSS27 plasmid in S. Typhimurium was not affected by the generations. (C) Plasmid stability of pSS27 carrying APEC O1 O-antigen gene cluster, strains cluster. Strains of S739 and S740 carrying plasmid pSS26 or pSS27 were subcultured every 12 h for 3 days in non-selective medium. Plasmid stability was determined as the percentage of colonies (out of 100 selected) growing on selective media.
Further analysis of the IgA antibody response from the intestinal wash samples also revealed that oral immunization of derivate strains of S739 induced a similar antibody level against S. Typhimurium LPS, and oral administration of S739 induced a greater IgA antibody level against S. Typhimurium LPS than S740 (P < 0.05) (Fig. 5C ). Oral immunization of strains carrying pSS27 induced a greater IgA antibody level against APEC O1 LPS than strains with pSS26 (empty plasmid) or BSG control (P < 0.05) (Fig.  5D ). Intramuscular immunization of each strain did not induce IgA antibody production in the chicks. As expected, i.m. induced stronger humoral immune responses than oral immunization, whereas oral administration of the vaccines contributed to induction of a mucosal immune response.
Determination of protective efficacy against APEC O1 challenge
The immunized birds were challenged with APEC O1 serotype strain C24-2 by either air sac or i.m. routes for 10 days after the second immunization and were monitored daily for 14 days. The negative control group administered BSG or strains harboring empty plasmid pSS26 resulted in 84% to 100% mortality regardless of the immunization and challenge routes (Table 3) .
Oral immunization of chickens with S740 (pSS27) and S739 (pSS27) provided 66.7% and 50% protective efficacy against air sac challenge with E. coli C24-2, respectively, and oral immunization of chickens with S740 (pSS27) and S739 (pSS27) provided 100% and 80% protective efficacy against i.m. challenge with E. coli C24-2, respectively, showing a significantly enhanced protection rate compared to groups inoculated with either control plasmid alone or BSG (P < 0.05). Intramuscular immunization with S740 (pSS27) and S739 (pSS27) conferred 50% and 0% protective efficacy against air sac challenge, respectively, and there is no significant difference between groups immunized with strains harboring pSS27 (APEC O1 antigen) and pSS26 (empty vector). Intramuscular immunization with S740 (pSS27) and S739 (pSS27) conferred 100% and 66.7% protective efficacy against i.m. challenge, respectively, showing significant higher protection than conferred by empty vector control group or BSG (P < 0.05). The results indicate that the oral immunization route appeared to be more effective in inducing protective immunity against bacterial challenge than the i.m. route. In addition, air sac immunization seems to be a more aggressive approach to evaluate protection efficacy than i.m., as challenge via the air sac route resulted in more chicken deaths compared to the group challenged by i.m. It also indicates that heterologous O1 O-antigen polysaccharide delivered by attenuated Salmonella S740 ( asd-66 crp-24 cya-25 rfbP45) might be a promising vaccine candidate to prevent avian pathogenic E. coli O1 serotype infection.
DISCUSSION
Our primary purpose is to construct a universal attenuated Salmonella vaccine to provide protection against three APEC serotypes infection in chicken farm, including APEC O1, O2 and O78. APEC O1 is one of the three predominant serotypes that cause field infection, and no vaccine against APEC O1 is available now. O-antigen polysaccharide surrounding bacterial pathogens represents a major virulence determinant and a major immunogen (Ahmed et al. 2006) , and vaccines based on polysaccharide have great potential for preventing APEC infection. We targeted APEC O1 pathogen and its O-antigen delivered in attenuated Salmonella vaccine in this study.
Traditional polysaccharide vaccines were called polysaccharide-protein conjugated vaccines, requiring polysaccharide purification from the target pathogens and chemical ligation to protein (Huang and Wu 2010) . As Salmonella can biologically synthesize polysaccharides in living cells and these polysaccharides can be ligated to lipid A core moiety and covalently coupled to outer membrane proteins, thereby inducing systemic immune responses against heterologous antigens, recombinant attenuated Salmonella has been widely used as a platform to synthesize and deliver pathogen-related polysaccharides (Attridge et al. 1990; Roland, Curtiss and Sizemore 1999; Xu et al. 2002) . Two methods have been employed to clone O-antigen gene clusters and to synthesize O-antigen polysaccharide in bacterial cells. The initial way is to clone the O-antigen gene cluster into a low-copy plasmid or a cosmid. The drawback of this method is the requirement of long PCR and enzymes cut and ligation, leading to a high probability of errors (Goldberg et al. 1992) . Furthermore, genetic instability is encountered when attempting to remove selective markers of antibiotic resistance from plasmids. To overcome this problem, the insertion of a heterologous O-antigen gene cluster into the bacterial chromosome was adopted. While this method can provide genetic stability of O-antigen gene cluster in the host, it still requires long PCR, digestion and ligation, and the efficacy of this method is low (Goldberg et al. 1992; Roland, Curtiss and Sizemore 1999) . Phage carrying O-antigen gene clusters may also be exploited to switch the O-serotype within the same species, such as in Salmonella enterica, but this approach is difficult to manipulate (Hone et al. 1994) . The shuttle plasmid created here provides an alternative way to assemble gene clusters for APEC O1 O-antigen polysaccharide synthesis in Salmonella. The polysaccharide gene cluster was assembled into the low-copy plasmid pSS26 by one-step recombination in yeast instead of by traditional enzyme digestion and ligation, thus reducing the operation of DNA in vitro (Huang and Wu 2010) . In addition, this shuttle plasmid could be stably maintained in Salmonella when grown in LB broth without antibiotics, which differs from other antibiotic-relying shuttle plasmids, to survive in the host as described previously (Nakayama, Kelly and Curtiss 1988) .
Attenuated Salmonella Typhimurium has been widely used as a polysaccharide vaccine delivery platform, and most heterologous polysaccharide antigen in previous studies were delivered by smooth Salmonella, which possesses complete LPS structure, resulting in induction of dual anti-LPS immune responses (Attridge et al. 1990; Roland, Curtiss and Sizemore 1999; Xu et al. 2002; Dharmasena et al. 2013) . The carrier LPS might impair foreign O-antigen polysaccharide immunogenicity, and removal or truncation of Salmonella O-antigen may alleviate this problem. In particular, truncation of O-antigen markedly attenuated Salmonella virulence, as Salmonella O-antigen is an essential virulence determinant that affects Salmonella infection and survival in the host (Nagy et al. 2006) , and has significant impacts on the immunogenicity induced by Salmonella (Kong et al. 2011) . To compare the effects of Salmonella O-antigen polysaccharide on immunogenicity, we constructed two Salmonella mutants to deliver pSS27. One was S740 ( asd-66 crp-24 cya-25 rfbP45) , in which O-antigen polysaccharide of Salmonella was absent, while only O-antigen polysaccharide derived from APEC O1 was present on Salmonella surface, and the other was S739 ( asd-66 crp-24 cya-25) with dual O-antigen polysaccharides on the surface. Our results demonstrated that removal of Salmonella O-antigen would contribute to an enhanced induction of the immune response against heterologous polysaccharide ( Fig. 5B and D) . The result of the immunity induced by Salmonella rfbP mutant strain carrying a complete lipid A core without any O-antigen units was consistent with the rfc (wzy) mutant, generating a strain generating lipid A core with one O-unit, which was used to deliver an Escherichia coli O78 O-antigen polysaccharide (Ewers et al. 2007) . It seems that the lipid A core of Salmonella LPS with one O-unit did not affect ligation with heterologous O-PS. The advantage of mutation of rfc or rfbP applying for delivering heterologous polysaccharide remains unknown and requires further investigations in the future.
The other factors that need to be optimized are the immunization route and the challenge route. To explore more effective protection conferred by attenuated Salmonella delivering APEC O1 O-antigen polysaccharide for future field trials, we compared diverse immunization routes and challenge approaches. Intramuscular administration is one of three licensed parenteral vaccine administration routes and can typically stimulate systemic immune responses (Herzog 2014) . The air sac route is one of the mimic natural route of APEC infection and thus provides an excellent opportunity to evaluate vaccine candidates (Dziva 2010; Ghunaim, Abu Madi and Kariyawasam 2014) ; oral administration seems to be the most attractive and promising route among all possible mucosal immunizations despite the fact that the oral route requires a high vaccine dose (Kang, Song and Kim 2012) . Therefore, oral and i.m. route were chosen as the immunization routes, and air sac and i.m route were selected for E. coli APEC O1 challenge.
Independent of the immunization and challenge route, Salmonella vaccine S740 (pSS27) solely synthesizing APEC O1 Oantigen polysaccharide conferred better protection than S739 (pSS27) expressing dual O-antigen polysaccharides (Fig. 5) . This result may be due to enhanced humoral immunity against APEC O1 O-antigen polysaccharide induced by Salmonella vaccine S740 (pSS27), which thereby promotes serum-killing functions including direct killing via agglutination and serum-mediated opsonophagocytosis by macrophages (Bridge et al. 2016) .
While both routes of immunization of either S740 (pSS27) or S739 (pSS27) induced similar protective immunity against i.m. challenge, oral immunization conferred more effective protection against air sac challenge than i.m. immunization (Fig. 5) . One possible explanation is that oral mucosal vaccination induced relative mucosal antibody production (IgA) on mucosal surfaces, such as the respiratory tract, to prevent infection of APEC O1 via air sac challenge, although it still elicited an extensive humoral immune response (Richardson et al. 2011) . Overall, oral vaccination appears to be a viable vaccination approach in chick models of APEC infection.
In conclusion, the present work reports a novel prokaryote-S. cerevisiae shuttle vector pSS26 for facilitating O-antigen gene cluster and stable maintenance in the host without antibiotic pressure. The successful expression of the E. coli O1 O-antigen gene cluster in S. Typhimurium using this shuttle vector indicates that this is a convenient, straightforward, highly efficient system for biosynthesizing conjugated O-antigen polysaccharide vaccines. Furthermore, attenuated Salmonella vaccines with plasmid pSS27 carrying O1 O-antigen gene cluster elicited strong protective immunity against virulent APEC, which has great potential to protect against E. coli disease in poultry. We are currently working on construction to cover other two APEC serotypes, O2 and O78, to develop a broad protective vaccine for APEC infection.
